In vivo blockade of CCL2 activity reduced the severity of CVB3-induced myocarditis, and the main mechanism may be related to effective inhibition of chemotaxis and reduction of systemic and local Th1 immune responses (37). The gene discussed is CCL2; the disease is myocarditis.